Analgesics in Russia

Publication Date	December 2007
Publisher	Euromonitor
Product Type	Report
Pages	45
ISBN Number	not applicable
Product Code	EUR00673

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

Euromonitor International's Analgesics in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (20012006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: adult analgesics, childspecific analgesics, systemic analgesics, topical analgesics Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

Get a detailed picture of the analgesics industry
Pinpoint growth sectors and trends and identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use fiveyear forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Executive Summary
- Another Good Year for Otc
- despite A Still Unfavourable Context
- Almost All Sectors Benefit from An Improvement
- Some Players More Dynamic than Others in A Highly Fragmented Competitive Environment
- Slightly Better Fate Anticipated
Key Trends and Developments
- Local Policy Still Strongly Impacts Otc Sales
- Possible Lower Pressure regarding Switches and Distribution
- Economic Development Should Be More Favourable
- The Quest of Longevity and Health and Wellness Fuels Vds
- Is The Success of Functional Food and Beverage and Some Cosmetic & Toiletries A Threat or An Opportunity?
- Increasingly Tough and Maybe Less Fragmented Competitive Environment
Appendix
- Otc Registration and Classification
- DeListing or DeReimbursement
- Advertising
- Packaging and Labelling
- Distribution
- Vitamins & Dietary Supplements Registration and Classification
- Generics
Appendix
- Consumer Expenditure on Health Goods and Medical Services
Market Indicators
Market Data
Definitions
Sources
Local Company Profile Belgium
- Arkopharma Belux Sa Otc Healthcare Belgium
  - Strategic Direction
  - Key Facts
  - Company Background & Production
  - Competitive Positioning
- Biodynamics Nv Otc Healthcare Belgium
  - Strategic Direction
  - Key Facts
  - Company Background & Production
  - Competitive Positioning
- Omega Pharma Nv Otc Healthcare Belgium
  - Strategic Direction
  - Key Facts
  - Company Background
  - Production
  - Competitive Positioning
- Patch Pharma Sa Otc Healthcare Belgium
  - Strategic Direction
  - Key Facts
  - Company Background & Production
  - Competitive Positioning
- Vemedia Pharma Nv Otc Healthcare Belgium
  - Strategic Direction
  - Key Facts
  - Company Background
  - Production
  - Competitive Positioning
  - Wound treatments in Belgium
  - Overview
  - Sector Data
List of Summaries
- Summary 1 Research Sources
- Summary 2 Arkopharma Belux Sa: Key Facts
- Summary 3 Arkopharma Belux Sa: Operational Indicators
- Summary 4 Arkopharma Belux Sa: Production Statistics 2005
- Summary 5 Arkopharma Belux Sa: Competitive Position 2006
- Summary 6 Biodynamics Bvba: Key Facts
- Summary 7 Biodynamics Bvba: Production Statistics 2006
- Summary 8 Summary Biodynamics Bvba: Competitive Position 2006
- Summary 9 Omega Pharma Belgium Nv: Key Facts
- Summary 10 Omega Pharma Belgium Nv: Operational Indicators
- Summary 11 Omega Pharma Belgium Nv: Production Statistics 20042005
- Summary 12 Summary Omega Pharma Belgium Nv: Competitive Position 2006
- Summary 13 Patch Pharma Nv Sa: Key Facts
- Summary 14 Vemedia Pharma Nv: Key Facts
- Summary 15 Vemedia Pharma Nv: Production Statistics 2005
- Summary 16 Summary Vemedia Pharma Nv: Competitive Position 2006
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 20012006
- Table 2 Life Expectancy at Birth 20012006
- Table 3 Sales of Otc Healthcare by Sector: Value 20012006
- Table 4 Sales of Otc Healthcare by Sector: % Value Growth 20012006
- Table 5 Otc Healthcare Company Shares by Retail Value 20022006
- Table 6 Otc Healthcare Brand Shares by Retail Value 20032006
- Table 7 Penetration of Private Label by Sector 20022006
- Table 8 Sales of Otc Healthcare by Distribution Format: % Analysis 2001/2006
- Table 9 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2006
- Table 10 Forecast Sales of Otc Healthcare by Sector: Value 20062011
- Table 11 Forecast Sales of Otc Healthcare by Sector: % Value Growth 20062011
- Table 12 Sales of Wound Treatments by Subsector: Value 20012006
- Table 13 Sales of Wound Treatments by Subsector: % Value Growth 20012006
- Table 14 Wound Treatments Company Shares by Retail Value 20022006
- Table 15 Wound Treatments Brand Shares by Retail Value 20032006
- Table 16 Forecast Sales of Wound Treatments by Subsector: Value 20062011
- Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 20062011